Skip to content

The EU Commission endorses substantial financial aid, amounting to billions of euros, for TSMC's semiconductor manufacturing facility in Dresden.

In a statement issued on Tuesday, the EU Commission in Brussels endorsed a five billion euro subsidy for Taiwan Semiconductor Manufacturing Company (TSMC) to establish a chip factory in Dresden. This move is expected to boost Europe's semiconductor technology sector, enhancing its supply...

The EU Commission endorses substantial financial aid, amounting to billions of euros, for TSMC's semiconductor manufacturing facility in Dresden.

TSMC is running operations in Dresden, Germany, as part of a collaboration called ESMC with Infineon, Bosch, and NPX from the Netherlands. The upcoming facility, projected to cost more than 10 billion euros, is primarily focused on manufacturing auto-related microchips. The production is scheduled to start by the end of 2027, generating approximately 2,000 jobs.

Tuesday saw the Commission highlighting that the Dresden site would operate with an open manufacturing model, enabling customers to customize their chip orders. There's also a commitment to aid small and medium-sized businesses and startups across Europe, helping them enhance their proficiency and knowledge. European universities will enjoy exclusive access to production capacities, fostering scholarly research and knowledge growth in Europe.

The approval of the billion-euro funding for the Dresden factory stems from the European Chips Act subsidy program. The legislation aims to elevate the EU's semiconductor production share worldwide from 10% to 20% by 2030.

The European Commission announced that 'The following shall be added:' to the Dresden site's operations, which includes providing support for customized chip orders for customers and facilitating access to production capacities for European universities. This initiative is expected to stimulate research and knowledge growth in the continent.

Read also:

Comments

Latest

The medication named Mounjaro, developed by Eli Lilly, has significantly decreased the likelihood...

The medication Mounjaro, developed by Eli Lilly, has significantly decreased the likelihood of diabetes-related issues.

The medication Mounjaro, developed by Eli Lilly, has significantly decreased the likelihood of diabetes-related issues. Eli Lilly's weight loss medication Mounjaro, specifically Tirzepatide, slashes diabetes risk by 94% in long-term trial. For adults with prediabetes and obesity or excess weight, this decrease was seen with drug treatment, according

Members Public
Gold's value soars to unprecedented heights.

Gold's value soars to unprecedented peak.

Gold's value soars to unprecedented peak. The price of gold saw a steady rise, propelled by the possibility of decreasing interest rates in the U.S., reaching an unprecedented peak. In the trading scene of London, the value hit an unmatched height of approximately $2,525 per troy

Members Public